Suchergebnisse - "Lennox, Jeffrey L"

PubPharm (138)

31

A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial

enthalten in: Clinical infectious diseases | 2016

von Ofotokun, I. | Titanji, K. | Lahiri, C. | +10

32

Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia

enthalten in: Open forum infectious diseases | 2015

von Vardhanabhuti, S. | Ribaudo, H. | Landovitz, R. | +5

33

Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure : ACTG 5257

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2015

von Ofotokun, I. | Na, L. | Landovitz, R. | +103

34

Three nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1

enthalten in: Annals of internal medicine | 2015

von Lennox, J. | Landovitz, R. | Ribaudo, H.

CommentOn: Ann Intern Med. 2014 Oct 7;161(7):461-71. - PMID 25285539

35

Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257

in: Clinical Infectious Diseases | 2015

von Ofotokun, I. | Na, L. | Landovitz, R. | +15

36

Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257

enthalten in: Clinical infectious diseases | 2015

von Ofotokun, I. | Na, L. | Landovitz, R. | +15

37

Three nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1

enthalten in: Annals of internal medicine | 2015

von Lennox, J. | Landovitz, R. | Ribaudo, H.

38

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV : 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014

von Lucas, G. | Ross, M. | Stock, P. | +11

CommentIn: Am J Kidney Dis. 2015 Jun;65(6):823-5. - PMID 25700555

39

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection

enthalten in: PLoS pathogens | 2014

von Titanji, K. | Vunnava, A. | Sheth, A. | +8

40

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1 : a randomized, controlled equivalence trial

enthalten in: Annals of internal medicine | 2014

von Lennox, J. | Landovitz, R. | Ribaudo, H. | +28

ErratumIn: Ann Intern Med. 2014 Nov 4;161(9):680